Integra LifeSciences IART Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's total liabilities?
- Integra LifeSciences (IART) reported total liabilities of $2.54B in Q1 2026.
- How has Integra LifeSciences's total liabilities changed year-over-year?
- Integra LifeSciences's total liabilities increased by 0.3% year-over-year, from $2.53B to $2.54B.
- What is the long-term trend for Integra LifeSciences's total liabilities?
- Over 5 years (2020 to 2025), Integra LifeSciences's total liabilities has grown at a 4.0% compound annual growth rate (CAGR), from $2.1B to $2.56B.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.